Search company, investor...

Total Raised

$49.5M

Investors Count

6

Deal Terms

2

Funding, Valuation & Revenue

4 Fundings

Zikani Therapeutics has raised $49.5M over 4 rounds.

Zikani Therapeutics's latest funding round was a Acquired for on April 1, 2021.

Zikani Therapeutics's valuation in April 2018 was $75M.

Zikani Therapeutics's latest post-money valuation is from April 2018.

Sign up for a free demo to see Zikani Therapeutics's valuations in March 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/1/2021

Acquired

$99M

0

FY undefined

3

4/16/2020

Series A - III

$99M

$99M

0

FY undefined

10

4/2/2018

Series A - II

$99M

$75M

0

FY undefined

10

3/4/2015

Series A

$99M

$99M

0

FY undefined

10

Date

4/1/2021

4/16/2020

4/2/2018

3/4/2015

Round

Acquired

Series A - III

Series A - II

Series A

Amount

$99M

$99M

$99M

Investors

Valuation

$99M

$99M

$75M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Zikani Therapeutics Deal Terms

2 Deal Terms

Zikani Therapeutics's deal structure is available for 2 funding rounds, including their Series A - II from April 02, 2018.

Round

Series A - II

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A - II

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Zikani Therapeutics Investors

6 Investors

Zikani Therapeutics has 6 investors. Eloxx Pharmaceuticals invested in Zikani Therapeutics's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/1/2021

4/1/2021

1
Acquired

Corporation

Massachusetts

00/00/0000

00/00/0000

Roche Venture Fund

Subscribe to see more

Corporate Venture

Switzerland

00/00/0000

00/00/0000

Gurnet Point Capital

Subscribe to see more

Private Equity

Massachusetts

00/00/0000

00/00/0000

Advent Life Sciences

Subscribe to see more

Venture Capital

United Kingdom

00/00/0000

00/00/0000

SR One

Subscribe to see more

Subscribe to see more

Venture Capital

Pennsylvania

First funding

4/1/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

4/1/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Roche Venture Fund

Gurnet Point Capital

Advent Life Sciences

SR One

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Corporate Venture

Private Equity

Venture Capital

Venture Capital

Location

Massachusetts

Switzerland

Massachusetts

United Kingdom

Pennsylvania

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.